Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 6
2011 7
2012 7
2013 9
2014 5
2015 1
2016 1
2017 3
2018 9
2019 6
2020 11
2021 8
2022 10
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE-A.
Pratz KW, DiNardo CD, Selleslag D, Li J, Yamamoto K, Konopleva M, Stevens D, Kantarjian H, Traina F, Venditti A, Mayer J, Montez M, Jin H, Duan Y, Brackman D, Zha J, Potluri J, Werner M, Jonas BA. Pratz KW, et al. Among authors: duan y. Am J Hematol. 2022 Nov;97(11):E416-E419. doi: 10.1002/ajh.26692. Epub 2022 Sep 16. Am J Hematol. 2022. PMID: 36054316 Free article. No abstract available.
Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and IDH1/2 Mutations.
Pollyea DA, DiNardo CD, Arellano ML, Pigneux A, Fiedler W, Konopleva M, Rizzieri DA, Smith BD, Shinagawa A, Lemoli RM, Dail M, Duan Y, Chyla B, Potluri J, Miller CL, Kantarjian HM. Pollyea DA, et al. Among authors: duan y. Clin Cancer Res. 2022 Jul 1;28(13):2753-2761. doi: 10.1158/1078-0432.CCR-21-3467. Clin Cancer Res. 2022. PMID: 35046058 Free PMC article.
Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid Leukemia.
Konopleva M, Thirman MJ, Pratz KW, Garcia JS, Recher C, Pullarkat V, Kantarjian HM, DiNardo CD, Dail M, Duan Y, Chyla B, Potluri J, Miller CL, Wei AH. Konopleva M, et al. Among authors: duan y. Clin Cancer Res. 2022 Jul 1;28(13):2744-2752. doi: 10.1158/1078-0432.CCR-21-3405. Clin Cancer Res. 2022. PMID: 35063965 Free PMC article.
Is Tamsulosin Linked to Dementia in the Elderly?
Frankel JK, Duan Y, Albertsen PC. Frankel JK, et al. Among authors: duan y. Curr Urol Rep. 2018 Jul 3;19(9):69. doi: 10.1007/s11934-018-0821-0. Curr Urol Rep. 2018. PMID: 29971698 Review.
Quinoid glycosides from Forsythia suspensa.
Li C, Dai Y, Zhang SX, Duan YH, Liu ML, Chen LY, Yao XS. Li C, et al. Phytochemistry. 2014 Aug;104:105-13. doi: 10.1016/j.phytochem.2014.04.010. Epub 2014 May 12. Phytochemistry. 2014. PMID: 24833035
Generation and characterization of antagonistic anti-human CD39 nanobodies.
Menzel S, Duan Y, Hambach J, Albrecht B, Wendt-Cousin D, Winzer R, Tolosa E, Rissiek A, Guse AH, Haag F, Magnus T, Koch-Nolte F, Rissiek B. Menzel S, et al. Among authors: duan y. Front Immunol. 2024 Mar 25;15:1328306. doi: 10.3389/fimmu.2024.1328306. eCollection 2024. Front Immunol. 2024. PMID: 38590528 Free PMC article.
Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy.
Miyamoto T, Sanford D, Tomuleasa C, Hsiao HH, Olivera LJE, Enjeti AK, Gimenez Conca A, Castillo TBD, Girshova L, Martelli MP, Guvenc B, Delgado A, Duan Y, Garbayo Guijarro B, Llamas C, Lee JH. Miyamoto T, et al. Among authors: duan y. Leuk Lymphoma. 2022 Apr;63(4):928-938. doi: 10.1080/10428194.2021.2002321. Epub 2022 Feb 11. Leuk Lymphoma. 2022. PMID: 35147482
79 results